Real Brands, Inc. (RLBD) licenses CBD Pharmacy(R) trademark

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
89
Real Brands, Inc. (RLBD) licenses CBD Pharmacy(R) trademark

FORT LAUDERDALE, FL--(Marketwired - Oct 19, 2017) - Real Brands, Inc. (OTC PINK: RLBD) is pleased to announce today that they have licensed the CBD Pharmacy® trademark for the sale of Vape Cartridges and other potential legal hemp and cannabis consumer products.

"We are excited to have the opportunity to license the CBD Pharmacy® trademark to Dragons, Ltd for immediate sale of Vape Cartridges," said Jerry Pearring, CEO of Real Brands, Inc. "This partnership will enable us to quickly establish the CBD Pharmacy® brand into the legal hemp and cannabis industry while allowing us to focus more time on the Omega Hemp Water® brand as we explore additional branded opportunities.

"We anticipate this licensing agreement to generate royalty income before the end of 2017 and we are already exploring additional CBD Pharmacy® branded legal hemp and cannabis consumer products to add to this licensing agreement," said Pearring. 

About Real Brands

Real Brands, Inc. (RLBD) is a publicly held brand building company active in the legal cannabis and hemp industry. The Company recently acquired the Omega Hemp Water™ trademark from Alkame Holdings, Inc. and the CBD Pharmacy® trademark as well as four (4) Colorado trademarks (Marijuana Cigarettes, Cannabis Cigarettes, Hemp Cigarettes and Cannabis Smoke Tobacco) and four (4) utility patents (An Inhaler for the consumption of Cannabinoids, Cannabis Infused Chewing Composition, A Method of Manufacturing a Smokable Cannabis Product and Cannabis Smokeless Tobacco). For additional information contact:

Safe Harbor Statement

Any statements in this press release that relate to Real Brands' expectations with regard to the future impact on its results are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements might not occur. Real Brands undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in Real Brands' plans or expectations.

Interviews and imagery available upon request

Jerry Pearring jerry@realbrandsusa.com 954-270-5309

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the $2.7 Billion Bid for Papa John’s: An Investment Insight

Updated Category News Views 229

Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...

Continue Reading
Key Highlights from Octopus Apollo VCT plc AGM Results

Updated Category News Views 105

Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...

Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance

Updated Category News Views 104

Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...

Continue Reading
Epinephrine Market Growth Insights and Future Potential

Updated Category News Views 112

Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...

Continue Reading
Canadian North Resources Achieves Major Milestones in Q2 2025

Updated Category News Views 183

Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....

Continue Reading